Andrew Le, MD
Dr. Le obtained his MD from Harvard Medical School and his BA from Harvard College. Before Buoy, his research focused on glioblastoma, a deadly form of brain cancer. Outside of work, Dr. Le enjoys cooking and struggling to run up-and-down the floor in an adult basketball league.
Education and training
2010 - 2017 - MD, Harvard Medical School
2006 - 2010 - BA (Economics), Harvard University
Publication Highlights
Publications
Redjal, N., Reinshagen, C., Le, A. et al. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide. J Neurooncol (2016) 127: 505.
Foulds CE, Tsimelzon A, Long W, Le, A., et al. Research resource: expression profiling reveals unexpected targets and functions of the human steroid receptor RNA activator (SRA) gene. Mol Endocrinol. 2010;24(5):1090–1105. doi:10.1210/me.2009-0427
Buoy articles
Why We Started Our Health Company
Why We're Coming Out of Stealth Mode
News Articles
Buoy Health Raises $15M in Series B Funding
Buoy Health partners with CVS Health to provide easy access to affordable care.